监管-话题@MedSci

#监管#

298篇内容 | 4566人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1371665, encodeId=b6f913e166521, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=五问兰州兽研所：96人布病抗体阳性，日常监管缘何失防？, objectType=article, longId=184467, objectId=451318446ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=451318446ef1, replyNumber=0, likeNumber=43, createdTime=2019-12-10, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=451318446ef1, moduleTitle=五问兰州兽研所：96人布病抗体阳性，日常监管缘何失防？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=451318446ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371664, encodeId=04d713e16643c, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=中医药纳入ICD-11遭质疑，欧洲两大权威组织呼吁加强监管, objectType=article, longId=183340, objectId=7a9418334005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a9418334005, replyNumber=0, likeNumber=72, createdTime=2019-11-22, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a9418334005, moduleTitle=中医药纳入ICD-11遭质疑，欧洲两大权威组织呼吁加强监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a9418334005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371663, encodeId=628513e1663e4, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=共话生物类似药的复杂性及监管策略, objectType=article, longId=182454, objectId=bb6e182454b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6e182454b0, replyNumber=0, likeNumber=51, createdTime=2019-11-07, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6e182454b0, moduleTitle=共话生物类似药的复杂性及监管策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6e182454b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371662, encodeId=323113e16624a, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=中国监管机构有条件批准绿谷药业甘露寡糖二酸治疗轻度至中度阿尔茨海默病, objectType=article, longId=182362, objectId=f1f4182362f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1f4182362f6, replyNumber=0, likeNumber=108, createdTime=2019-11-06, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1f4182362f6, moduleTitle=中国监管机构有条件批准绿谷药业甘露寡糖二酸治疗轻度至中度阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1f4182362f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371661, encodeId=8c0e13e166116, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=医疗机构监管再升级，严查！, objectType=article, longId=182063, objectId=479618206331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=479618206331, replyNumber=0, likeNumber=63, createdTime=2019-10-30, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=479618206331, moduleTitle=医疗机构监管再升级，严查！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=479618206331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371660, encodeId=992213e16603e, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案, objectType=article, longId=181799, objectId=6cee181e9981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cee181e9981, replyNumber=0, likeNumber=59, createdTime=2019-10-24, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cee181e9981, moduleTitle=Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cee181e9981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371659, encodeId=273113e165917, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=广西全程监管医药“购销用”：禁止引导患者到指定药店购药, objectType=article, longId=180779, objectId=5b44180e795c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b44180e795c, replyNumber=0, likeNumber=32, createdTime=2019-10-10, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b44180e795c, moduleTitle=广西全程监管医药“购销用”：禁止引导患者到指定药店购药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b44180e795c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371658, encodeId=0f4213e1658b3, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=监管、人才、资本，心理医疗市场到底缺什么, objectType=article, longId=180579, objectId=fea01805e9f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fea01805e9f5, replyNumber=0, likeNumber=60, createdTime=2019-10-07, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fea01805e9f5, moduleTitle=监管、人才、资本，心理医疗市场到底缺什么, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fea01805e9f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371657, encodeId=d82613e16576a, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=国务院发文：医械行业筛选重点企业监管！, objectType=article, longId=179783, objectId=379c1e9783bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379c1e9783bf, replyNumber=0, likeNumber=56, createdTime=2019-09-22, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379c1e9783bf, moduleTitle=国务院发文：医械行业筛选重点企业监管！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379c1e9783bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371656, encodeId=196b13e165635, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=不用担心虚假宣传了南京对医疗卫生领域实行信用分类监管, objectType=article, longId=179637, objectId=a6aa1e96375a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6aa1e96375a, replyNumber=0, likeNumber=74, createdTime=2019-09-19, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6aa1e96375a, moduleTitle=不用担心虚假宣传了南京对医疗卫生领域实行信用分类监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6aa1e96375a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371655, encodeId=95d813e1655b3, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=国务院印发指导意见对直接涉及人民群众生命健康的领域实行全覆盖重点监管, objectType=article, longId=179379, objectId=28ce1e9379aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ce1e9379aa, replyNumber=0, likeNumber=54, createdTime=2019-09-14, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ce1e9379aa, moduleTitle=国务院印发指导意见对直接涉及人民群众生命健康的领域实行全覆盖重点监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ce1e9379aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371654, encodeId=b54213e1654b7, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, objectType=article, longId=178850, objectId=de591e885009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de591e885009, replyNumber=0, likeNumber=61, createdTime=2019-09-06, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de591e885009, moduleTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de591e885009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371653, encodeId=069b13e1653db, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=保健食品新政来了，市场监管总局副局长重点介绍了三个方面, objectType=article, longId=178086, objectId=4ea01e808625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea01e808625, replyNumber=0, likeNumber=69, createdTime=2019-08-23, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea01e808625, moduleTitle=保健食品新政来了，市场监管总局副局长重点介绍了三个方面, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea01e808625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371652, encodeId=5c1013e1652ac, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=取消GMP认证让门槛成为门槛让监管成为监管, objectType=article, longId=177499, objectId=12b31e7499be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12b31e7499be, replyNumber=0, likeNumber=60, createdTime=2019-08-14, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12b31e7499be, moduleTitle=取消GMP认证让门槛成为门槛让监管成为监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12b31e7499be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371651, encodeId=cab913e165110, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=电子烟有害！国家卫健委：计划立法对电子烟进行监管, objectType=article, longId=177349, objectId=91ae1e7349ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91ae1e7349ec, replyNumber=0, likeNumber=78, createdTime=2019-08-11, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91ae1e7349ec, moduleTitle=电子烟有害！国家卫健委：计划立法对电子烟进行监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91ae1e7349ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371650, encodeId=fdbb13e16509f, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=国家药监局发布系列APP 移动互联网助力药品监管, objectType=article, longId=176863, objectId=fdce1e6863cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdce1e6863cb, replyNumber=0, likeNumber=77, createdTime=2019-08-06, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdce1e6863cb, moduleTitle=国家药监局发布系列APP 移动互联网助力药品监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdce1e6863cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371649, encodeId=330813e164975, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=电子烟泛滥：立法监管电子烟势在必行, objectType=article, longId=176808, objectId=cfc41e6808fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc41e6808fe, replyNumber=0, likeNumber=60, createdTime=2019-08-05, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc41e6808fe, moduleTitle=电子烟泛滥：立法监管电子烟势在必行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc41e6808fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371648, encodeId=31bd13e16484a, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=2009-2018年六大监管机构的新药批准情况, objectType=article, longId=175526, objectId=53881e5526da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53881e5526da, replyNumber=0, likeNumber=55, createdTime=2019-07-17, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53881e5526da, moduleTitle=2009-2018年六大监管机构的新药批准情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53881e5526da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371647, encodeId=c82513e16477c, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=沃森生物董事长被举报，曾违规套现1.9亿吃监管函，市值蒸发10亿, objectType=article, longId=175287, objectId=fb871e528705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb871e528705, replyNumber=0, likeNumber=75, createdTime=2019-07-13, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb871e528705, moduleTitle=沃森生物董事长被举报，曾违规套现1.9亿吃监管函，市值蒸发10亿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb871e528705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1371646, encodeId=cb2213e16467f, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, objectTitle=重庆多举措加强医疗保障基金监管欲建“黑名单”, objectType=article, longId=175211, objectId=088a1e521176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=088a1e521176, replyNumber=0, likeNumber=54, createdTime=2019-07-13, rootId=0, userName=wwzzly, userId=b96f328, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=088a1e521176, moduleTitle=重庆多举措加强医疗保障基金监管欲建“黑名单”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=088a1e521176)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

监管

2020-05-29

wwzzly (审核中...)

前往app查看评论内容

#监管#

五问兰州兽研所：96人布病抗体阳性，日常监管缘何失防？

2019-12-10

wwzzly (审核中...)

前往app查看评论内容

#监管#

中医药纳入ICD-11遭质疑，欧洲两大权威组织呼吁加强监管

2019-11-22

wwzzly (审核中...)

前往app查看评论内容

#监管#

共话生物类似药的复杂性及监管策略

2019-11-07

wwzzly (审核中...)

前往app查看评论内容

#监管#

中国监管机构有条件批准绿谷药业甘露寡糖二酸治疗轻度至中度阿尔茨海默病

2019-11-06

wwzzly (审核中...)

前往app查看评论内容

#监管#

医疗机构监管再升级，严查！

2019-10-30

wwzzly (审核中...)

前往app查看评论内容

#监管#

Biogen将向FDA申请阿尔茨海默症治疗药物Aducanumab的监管备案

2019-10-24

wwzzly (审核中...)

前往app查看评论内容

#监管#

广西全程监管医药“购销用”：禁止引导患者到指定药店购药

2019-10-10

wwzzly (审核中...)

前往app查看评论内容

#监管#

监管、人才、资本，心理医疗市场到底缺什么

2019-10-07

wwzzly (审核中...)

前往app查看评论内容

#监管#

国务院发文：医械行业筛选重点企业监管！

2019-09-22

wwzzly (审核中...)

前往app查看评论内容

#监管#

不用担心虚假宣传了南京对医疗卫生领域实行信用分类监管

2019-09-19

wwzzly (审核中...)

前往app查看评论内容

#监管#

国务院印发指导意见对直接涉及人民群众生命健康的领域实行全覆盖重点监管

2019-09-14

wwzzly (审核中...)

前往app查看评论内容

#监管#

中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物

2019-09-06

wwzzly (审核中...)

前往app查看评论内容

#监管#

保健食品新政来了，市场监管总局副局长重点介绍了三个方面

2019-08-23

wwzzly (审核中...)

前往app查看评论内容

#监管#

取消GMP认证让门槛成为门槛让监管成为监管

2019-08-14

wwzzly (审核中...)

前往app查看评论内容

#监管#

电子烟有害！国家卫健委：计划立法对电子烟进行监管

2019-08-11

wwzzly (审核中...)

前往app查看评论内容

#监管#

国家药监局发布系列APP 移动互联网助力药品监管

2019-08-06

wwzzly (审核中...)

前往app查看评论内容

#监管#

电子烟泛滥：立法监管电子烟势在必行

2019-08-05

wwzzly (审核中...)

前往app查看评论内容

#监管#

2009-2018年六大监管机构的新药批准情况

2019-07-17

wwzzly (审核中...)

前往app查看评论内容

#监管#

沃森生物董事长被举报，曾违规套现1.9亿吃监管函，市值蒸发10亿

2019-07-13

wwzzly (审核中...)

前往app查看评论内容

#监管#

重庆多举措加强医疗保障基金监管欲建“黑名单”

2019-07-13

科室
- - 订阅+
  - 更多科室
工具
服务